SCR-LIP-000160 · Claim · machine-readable JSON →
In a 60-patient single-centre prospective cohort with stage I-II lipedema, tumescent liposuction produced large symptom improvements (effect sizes d=1.04-2.18 for spontaneous pain, pressure sensitivity, edema, bruising, movement restriction, cosmetic impairment and quality of life) that persisted at 12 years post-operatively with no clinically relevant deterioration, and 27% of patients no longer required any conservative therapy.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 4 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Improvements in patients with lipedema 4, 8 and 12 years after liposuction — Baumgartner et al. (2020) ✓ verified — consistent · cohort · 2020 · reading confidence: high
Prospective single-centre cohort of 60 stage I-II lipedema patients with 12-year follow-up via validated questionnaire shows durable, statistically significant symptom and quality-of-life improvements after liposuction, directly supporting
Context (PECO)
Answers these questions
- Is liposuction effective and safe for lipedema? consistent
- Does liposuction reduce pain in lipedema? consistent
- Does liposuction reduce limb volume in lipedema? consistent
- Does liposuction modify the disease course or cure lipedema? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created